產(chǎn)品名稱 SR 3029
產(chǎn)品貨號 Axon 2547 CAS [1454585-06-8] MF C23H19F3N8OMW 480.45 Purity: 99% Soluble in DMSO Description A potent, highly specific CK1δ/CK1ε inhibitor (IC50 values 44 nM and 260 nM for CK1δ, and CK1ε, respectively), that selectively inhibits breast cancer cell growth and survival. SR-3029 exhibits in vitro and in vivo PK properties suitable for use in xenograft studies of human cancers, including brain cancers. KEYWORDS: SR 3029 | supplier | CK1δ/CK1ε inhibitor | CK1 inhibitor | SR3029 | CAS [1454585-06-8] | casein kinase | CK1 | Inhibitor | breast cancer | brain cancer | Wnt | catenin | signaling | HER2 | FLT3 | CK1-delta | CK1-epsilon
產(chǎn)品價格 現(xiàn)貨詢價，電話：010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

SR 3029

Based on 19 reference(s) in Google Scholar 9 10 19

Axon 2547

CAS [1454585-06-8]

MF C23H19F3N8O
MW 480.45

  • Purity: 99%
  • Soluble in DMSO

SR 3029

Description

A potent, highly specific CK1δ/CK1ε inhibitor (IC50 values 44 nM and 260 nM for CK1δ, and CK1ε, respectively), that selectively inhibits breast cancer cell growth and survival. SR-3029 exhibits in vitro and in vivo PK properties suitable for use in xenograft studies of human cancers, including brain cancers.

KEYWORDS: SR 3029 | supplier | CK1δ/CK1ε inhibitor | CK1 inhibitor | SR3029 | CAS [1454585-06-8] | casein kinase | CK1 | Inhibitor | breast cancer | brain cancer | Wnt | catenin | signaling | HER2 | FLT3 | CK1-delta | CK1-epsilon
產(chǎn)品資料